X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13684) 13684
Book Review (2084) 2084
Publication (680) 680
Newsletter (667) 667
Conference Proceeding (178) 178
Book Chapter (93) 93
Newspaper Article (57) 57
Magazine Article (43) 43
Dissertation (26) 26
Trade Publication Article (16) 16
Web Resource (9) 9
Paper (5) 5
Transcript (3) 3
Book / eBook (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
clopidogrel (12984) 12984
index medicus (8724) 8724
humans (7940) 7940
aspirin (4936) 4936
male (4667) 4667
female (4225) 4225
ticlopidine - analogs & derivatives (4181) 4181
cardiac & cardiovascular systems (4099) 4099
middle aged (3470) 3470
aged (3395) 3395
platelet aggregation inhibitors - therapeutic use (3241) 3241
percutaneous coronary intervention (2610) 2610
ticlopidine - therapeutic use (2259) 2259
treatment outcome (2233) 2233
risk factors (2087) 2087
peripheral vascular disease (2011) 2011
acute coronary syndromes (1980) 1980
antiplatelet therapy (1946) 1946
platelet aggregation inhibitors - administration & dosage (1768) 1768
platelet aggregation inhibitors - adverse effects (1746) 1746
pharmacology & pharmacy (1736) 1736
prasugrel (1723) 1723
abridged index medicus (1702) 1702
ticagrelor (1672) 1672
myocardial-infarction (1587) 1587
hematology (1561) 1561
thrombosis (1556) 1556
stroke (1530) 1530
risk (1464) 1464
drug therapy, combination (1423) 1423
aspirin - therapeutic use (1419) 1419
coronary heart disease (1381) 1381
care and treatment (1365) 1365
ticlopidine - administration & dosage (1364) 1364
therapy (1348) 1348
drug therapy (1276) 1276
stents (1232) 1232
research (1223) 1223
acute coronary syndrome (1219) 1219
platelet aggregation - drug effects (1186) 1186
ticlopidine - adverse effects (1181) 1181
cardiac patients (1172) 1172
cardiology (1165) 1165
mortality (1134) 1134
prevention (1132) 1132
intervention (1120) 1120
adult (1110) 1110
time factors (1085) 1085
medicine, general & internal (1080) 1080
platelet aggregation inhibitors - pharmacology (1078) 1078
heart attacks (1063) 1063
analysis (1052) 1052
trial (1052) 1052
blood platelets (1042) 1042
cardiovascular (1019) 1019
aggregation (956) 956
aged, 80 and over (933) 933
prospective studies (930) 930
myocardial infarction (925) 925
blood platelets - drug effects (909) 909
dosage and administration (898) 898
platelets (895) 895
surgery (890) 890
cardiovascular disease (885) 885
cardiovascular diseases (882) 882
outcomes (878) 878
aspirin - administration & dosage (875) 875
acute coronary syndrome - drug therapy (836) 836
medical research (828) 828
acute myocardial-infarction (814) 814
inhibition (809) 809
patients (797) 797
ticlopidine - pharmacology (788) 788
transluminal angioplasty (786) 786
retrospective studies (767) 767
anticoagulants (759) 759
hemorrhage - chemically induced (749) 749
platelet reactivity (746) 746
medicine & public health (739) 739
medicine, experimental (739) 739
bleeding (737) 737
stent thrombosis (728) 728
artery-disease (714) 714
risk assessment (712) 712
angioplasty (706) 706
management (703) 703
ticlopidine (698) 698
health aspects (694) 694
dual antiplatelet therapy (683) 683
stent (682) 682
follow-up studies (676) 676
drug-eluting stents (675) 675
events (667) 667
warfarin (666) 666
platelet function tests (665) 665
aspirin - adverse effects (657) 657
metaanalysis (642) 642
platelet aggregation (639) 639
clinical trials (627) 627
double-blind (617) 617
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13730) 13730
German (248) 248
Spanish (171) 171
French (145) 145
Russian (128) 128
Polish (62) 62
Korean (39) 39
Japanese (37) 37
Chinese (33) 33
Italian (24) 24
Czech (21) 21
Portuguese (19) 19
Turkish (19) 19
Croatian (6) 6
Dutch (3) 3
Persian (3) 3
Slovak (3) 3
Hungarian (2) 2
Lithuanian (2) 2
Malay (2) 2
Romanian (2) 2
Serbian (2) 2
Swedish (2) 2
Belarusian (1) 1
Greek (1) 1
Norwegian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, Pharmacology-research, safety testing, and regulation series, ISBN 1629483362
Web Resource
Revista española de cardiología, ISSN 0300-8932, 2011, Volume 11, Issue 1, pp. 14 - 19
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 03/2018, Volume 46, Issue 3, pp. 291 - 291
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/2018, Volume 103, Issue 2, pp. 217 - 223
Only limited data are available regarding the treatment of critically ill patients with clopidogrel. This trial investigated the effects and the drug... 
PHARMACODYNAMIC RESPONSES | POLYMORPHISMS | PHARMACOKINETICS | HIGH-DOSE CLOPIDOGREL | ACUTE MYOCARDIAL-INFARCTION | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TREATMENT PLATELET REACTIVITY | PRASUGREL | CYP2C19 | CORONARY-ARTERY-DISEASE | Activation, Metabolic | Clopidogrel - blood | Humans | Middle Aged | Critical Illness | Half-Life | Male | Microfilament Proteins - blood | Clopidogrel - administration & dosage | Drug Monitoring - methods | Clopidogrel - pharmacokinetics | Pantoprazole - administration & dosage | Platelet Aggregation Inhibitors - blood | Austria | Pantoprazole - pharmacokinetics | Phosphoproteins - blood | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Proton Pump Inhibitors - blood | Blood Platelets - drug effects | Drug Resistance | Platelet Aggregation Inhibitors - adverse effects | Cell Adhesion Molecules - blood | Proton Pump Inhibitors - adverse effects | Down-Regulation | Cytochrome P-450 CYP2C19 - genetics | Biomarkers - blood | Pantoprazole - blood | Proton Pump Inhibitors - pharmacokinetics | Blood Platelets - metabolism | Pantoprazole - adverse effects | Cytochrome P-450 CYP2C19 - metabolism | Aged | Clopidogrel - adverse effects | Care and treatment | Usage | Critically ill | Clopidogrel | Cytochromes | Research | Health aspects | Index Medicus | Abridged Index Medicus | Clinical Trial
Journal Article
10/2011
Clopidogrel is prescribed in cardiac and extracardiac vascular diseases. It is generally well tolerated; however, few cases of taste disorders have been... 
clopidogrel | taste disorders | Ageusia
Web Resource
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2019, Volume 73, Issue 15, pp. S65 - S65
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2019, Volume 73, Issue 15, pp. S52 - S53
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, p. C71
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, p. C174
Journal Article
by Yang, Y.G and Zhang, M and Jiang, N and Song, L.X and Xu, X.T and Di, X.H and Xu, L and Xu, J and Zhao, G.T
Genetics and Molecular Research, ISSN 1676-5680, 12/2015, Volume 14, Issue 4, pp. 16736 - 16743
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 16, pp. C132 - C132
Objectives International multicenter clinical research (PLATO) confirmed that ticagrelor as a new type drug with stronger antithrombotic effect, significantly... 
Transluminal angioplasty | Angioplasty | Clopidogrel
Journal Article
Journal of Enam Medical College, ISSN 2227-6688, 02/2016, Volume 6, Issue 1, pp. 38 - 46
Antiplatelet agents are mainly used in the prevention and management of atherothrombotic complications. Dual antiplatelet therapy, combining aspirin and... 
some patients develop recurrent cardiovascular ischemic events especially stent thrombosis which is a serious clinical problem. Antiplatelet response to clopidogrel varies widely among patients based on ex vivo platelet function measurements. Clopidogrel is an effective inhibitor of platelet activation and aggregation due to its selective and irreversible blockade of the P2Y12 receptor. Patients who display little attenuation of platelet reactivity with clopidogrel therapy are labeled as low or nonresponders or clopidogrel resistant. The mechanism of clopidogrel resistance remains incompletely defined but there are certain clinical | India and Visiting Professor | is the standard care for patients having acute coronary syndromes or undergoing percutaneous coronary intervention according to the current ACC/AHA and ESC guidelines. But in spite of administration of dual antiplatelet therapy | No 1 > Neki Clopidogrel Resistance: Current Issues NS Neki Abstract Antiplatelet agents are mainly used in the prevention and management of atherothrombotic complications. Dual antiplatelet therapy | Department of Medicine | Amritsar | combining aspirin and clopidogrel | University of Minnitoba | Institute of Cardiovascular Sciences | cellular and genetic factors including polymorphisms responsible for therapeutic failure. Currently there is no standardized or widely accepted definition of clopidogrel resistance. The future may soon be realised in the routine measurement of platelet activity in the same way that blood pressure | Winnipeg | thus improving the care for millions of people. This review focuses on the methods used to identify patients with clopidogrel resistance | the underlying mechanisms | Government Medical College | Canada India Article Tools Print this article Indexing metadata How to cite item Finding References Email this article (Login required) Email the author (Login required) Information For Readers For Authors Home > Journal of Enam Medical College > Vol 6 | cholesterol and blood sugar are followed to help guide the therapy | Acute coronary syndrome; Percutaneous coronary intervention; Clopidogrel; Platelet aggregation | metabolism | and increase worldwide knowledge of indigenous scholarship. Read more. Browse By Issue By Author By Title Other Journals Login Username Password Remember me Journal Content Search Search Scope Browse By Issue By Author By Title Other Journals Subjects About The Author NS Neki Professor | Part of the JOL Project Supported by INASP Bangladesh Journals OnLine (BanglaJOL) is a service to provide access to Bangladesh published research
Journal Article
World journal of urology, ISSN 0724-4983, 02/2019, pp. 1 - 2
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 11/2012, Volume 27, Issue 11, pp. 2373 - 2386
Journal Article
European Heart Journal, ISSN 0195-668X, 8/2009, Volume 30, Issue 16, pp. 1964 - 1977
Currently, clopidogrel is recommended for treatment of patients with acute coronary syndrome and/or percutaneous coronary intervention. However, the delayed... 
Prasugrel | Clopidogrel | Thienopyridine | Cangrelor | Ticagrelor | Purinoceptor P2Y
Journal Article
AMERICAN JOURNAL OF THERAPEUTICS, ISSN 1075-2765, 05/2019, Volume 26, Issue 3, pp. E425 - E426
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 12/2018, Volume 72, Issue 6, pp. 296 - 302
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.